Pfizer LTD

Pfizer Ltd (PFIZER) is a small-cap Healthcare company valued at ₹17,448 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Pfizer Ltd last traded at ₹3,794.6, modestly down 0.43% on the day.

Recent developments

2026-08-04: Pfizer reported stronger-than-expected quarterly profits, driven by increased sales of its blood thinner Eliquis and cost management efforts, which contributed to a profit of 77 cents per share on an adjusted basis.

Financial performance

The company's annual revenue rose 10.5% to ₹2,520 crore, while annual net profit fell 5.9% to ₹722 crore. In the latest quarter, revenue grew 8.3% to ₹653 crore and net profit rose 6.5% to ₹204 crore, showing some resilience despite the annual profit decline.

Valuation multiples

The stock trades at 24.0 times earnings, a discount to the Healthcare median of 32.0, 4.46 times book value. It yields 1.8%.

Things to watch

The company's net profit margin narrowed 5.0 percentage points to 28.7%, and its annual net profit declined despite revenue growth. The stock is 30.8% below its 52-week high, and the latest quarter's net profit growth was modest compared to the prior year.

Where it stands

Pfizer Ltd's latest quarter showed improved profitability, with net profit rising 6.5% year-over-year, but annual net profit fell 5.9% amid a narrowing margin. The stock is significantly below its 52-week high, and the company's revenue growth has slowed in recent years.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.